Colgate-Palmolive (CL) financials
Colgate-Palmolive revenue and earnings by year
Colgate-Palmolive's revenue was $20.4 billion in the fiscal year to December 31, 2025, up 1.4% from the year before. Net income was $2.13 billion, 10.5% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 3.3% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 20.4 | 20.1 | 19.5 | 18.0 | 17.4 | 16.5 | 15.7 | 15.5 | 15.5 | 15.2 |
| Revenue growth | 1.4% | 3.3% | 8.3% | 3.1% | 5.8% | 5.0% | 1.0% | 0.6% | 1.7% | — |
| Gross profit | 12.3 | 12.2 | 11.3 | 10.2 | 10.4 | 10.0 | 9.3 | 9.2 | 9.3 | 9.1 |
| Gross margin | 60.1% | 60.5% | 58.2% | 57.0% | 59.6% | 60.8% | 59.4% | 59.4% | 60.0% | 60.0% |
| Operating income | 3.3 | 4.3 | 4.0 | 2.9 | 3.3 | 3.9 | 3.6 | 3.7 | 3.7 | 4.0 |
| Operating margin | 16.2% | 21.2% | 20.5% | 16.1% | 19.1% | 23.6% | 22.6% | 23.8% | 24.0% | 26.0% |
| Net income | 2.1 | 2.9 | 2.3 | 1.8 | 2.2 | 2.7 | 2.4 | 2.4 | 2.0 | 2.4 |
| Net margin | 10.5% | 14.4% | 11.8% | 9.9% | 12.4% | 16.4% | 15.1% | 15.4% | 13.1% | 16.1% |
| Diluted EPS | $2.63 | $3.51 | $2.77 | $2.13 | $2.55 | $3.13 | $2.75 | $2.75 | $2.28 | $2.72 |
| Free cash flow | 3.6 | 3.5 | 3.0 | 1.9 | 2.8 | 3.3 | 2.8 | 2.6 | 2.5 | 2.6 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open CL in Markets.
How Colgate-Palmolive makes money
Revenue by segment in the quarter to June 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Oral Personal & Home Care | $4.17B | 77.7% |
| Hills Pet Nutrition | $1.20B | 22.3% |
See also: CL valuation and P/E history · CL returns
No forecast, no recommendation. This page describes Colgate-Palmolive from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.